Welcome to BC PharmaCare's public survey of drugs being reviewed for coverage. This survey is for daridorexant (Quviviq) for the treatment of insomnia in adults diagnosed according to the most recent version of the Diagnostic and Statistical Manual of Mental Disorders (DSM) referring to chronic insomnia disorder (CID).